About Datar Genetics
Datar Genetics is a company based in Nashik (India) founded in 1992 by Rajan Datar. Datar Genetics has raised $2.98 million across 1 funding round from investors including Alkemi Partners. Datar Genetics offers products and services including Liquid Biopsy Tests and Circulating Tumor Cells Analysis. Datar Genetics operates in a competitive market with competitors including Guardant Health, Natera, Foundation Medicine, ArcherDX and Prenetics, among others.
- Headquarter Nashik, India
- Founders Rajan Datar
- Stage Minicorn
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Datar Cancer Genetics
-
Annual Revenue
$9.45 M (USD)-16as on Mar 31, 2024
-
Net Profit
-$896.03 K (USD)-227as on Mar 31, 2024
-
EBITDA
$2.47 M (USD)-49as on Mar 31, 2024
-
Total Equity Funding
$2.98 M (USD)
in 1 rounds
-
Latest Funding Round
$2.98 M (USD), Angel Round
Aug 26, 2024
- Investors
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Datar Genetics
Datar Genetics offers a comprehensive portfolio of products and services, including Liquid Biopsy Tests and Circulating Tumor Cells Analysis.
Non-invasive blood tests for early cancer detection and monitoring.
Tests evaluating tumor cells in blood for cancer progression tracking.
People of Datar Genetics
Unlock access to complete
Funding Insights of Datar Genetics
Datar Genetics has successfully raised a total of $2.98M through 1 strategic funding round. The most recent funding activity was a Angel Round of $2.98 million completed in August 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Datar Genetics
Datar Genetics has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Alkemi Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investment in early-stage healthcare companies for consumer well-being and growth.
|
Locked | Locked | Locked |
Investor details for Datar Genetics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Datar Genetics
Investment portfolio details for Datar Genetics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Datar Genetics
Detailed financials for Datar Genetics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Datar Genetics Comparisons
Peer comparison for Datar Genetics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Datar Genetics
Datar Genetics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Natera, Foundation Medicine, ArcherDX and Prenetics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Digital sequencing technology for cancer detection is developed.
|
|
| Locked | Locked | Locked |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| Locked | Locked | Locked |
Genomics-based diagnostic tests for cancer are provided.
|
|
| Locked | Locked | Locked |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| Locked | Locked | Locked |
Health risks are identified through online genetic and diagnostic testing.
|
|
| Locked | Locked | Locked |
Blood-based liquid biopsy tests for multiple cancer detection are provided.
|
Detailed competitors of Datar Genetics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Datar Genetics
Complete news archive for Datar Genetics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Datar Genetics
Datar Genetics was founded in 1992 and raised its 1st funding round 32 years after it was founded.
Datar Genetics is headquartered in Nashik, India. It is registered at Nashik, Maharashtra, India.
Datar Genetics is a funded company, having raised a total of $2.98M across 1 funding round to date.
Annual revenue of Datar Genetics is $9.45M as on Mar 31, 2024.
Datar Genetics was established in 1992 and is based in Nashik, India. Operations center on biotechnology for cancer diagnostics using liquid biopsy techniques. The product lineup consists of TruBlood for non-invasive malignancy detection, CellDx for tumor genome sequencing, Exacta for treatment personalization via tumor profiling, and ChemoScale for in-vitro evaluation of chemotherapy resistance. Focus remains on accessible, non-invasive testing in oncology.
Datar Genetics's top competitors include Guardant Health, Foundation Medicine and Natera.
Datar Genetics offers Liquid Biopsy Tests and Circulating Tumor Cells Analysis.
Datar Genetics has 1 investor. Key investors include Alkemi Partners.
The valuation of Datar Genetics is $77.53M as of Aug 2024.